InvestorsHub Logo
Followers 46
Posts 2781
Boards Moderated 9
Alias Born 01/28/2001

Re: TJG post# 2837

Saturday, 02/03/2024 5:11:04 PM

Saturday, February 03, 2024 5:11:04 PM

Post# of 6605
Seems to me Napo needed a Territory Sales Manager in the Mid-Atlantic Region

For the FDA approved use of Mytesi for HIV/AIDS treatment of antiretroviral therapy for non-infectious diarrhea in adults on ART therapy.

To influence targeted health care professional to support the use of Napo promoted product, Mytesi, for non-infectious diarrhea in adults on ART therapy.

To set in brand strategies to ensure a consistent sales and marketing.

If Phase III approval is just around the corner for the use of crofelemer for prophylaxis of diarrhea in adult cancer patients receiving targeted therapy then they will already be set up and ready if FDA approval is around the corner for preventive treatment of chemotherapy-induced overactive bowel (CIOB) in adults with cancer on targeted therapy. Jaguar family company Napo Therapeutics

Yes! It seems they are setting up to be ready for future uses of Mytesi crofelemer in the supply chain.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent JAGX News